Vivani Medical Shows Preclinical Data on Weight Loss Implants
![Vivani Medical Shows Preclinical Data on Weight Loss Implants](https://executives-edge.com/wp-content/uploads/2024/02/Screenshot-2024-02-28-at-10.07.58-AM.png)
By Daniella Parra Vivani Medical, Inc. (Nasdaq: VANI) reported promising preclinical data on NPM-115, a miniature exenatide implant for chronic weight management. The company focuses on GLP-1 implants for obesity treatment due to their potential to improve patient outcomes, which...